Correlation Between NioCorp Developments and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both NioCorp Developments and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NioCorp Developments and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NioCorp Developments Ltd and Tscan Therapeutics, you can compare the effects of market volatilities on NioCorp Developments and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NioCorp Developments with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NioCorp Developments and Tscan Therapeutics.
Diversification Opportunities for NioCorp Developments and Tscan Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between NioCorp and Tscan is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding NioCorp Developments Ltd and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and NioCorp Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NioCorp Developments Ltd are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of NioCorp Developments i.e., NioCorp Developments and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between NioCorp Developments and Tscan Therapeutics
Allowing for the 90-day total investment horizon NioCorp Developments Ltd is expected to under-perform the Tscan Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, NioCorp Developments Ltd is 1.64 times less risky than Tscan Therapeutics. The stock trades about -0.28 of its potential returns per unit of risk. The Tscan Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 495.00 in Tscan Therapeutics on September 2, 2024 and sell it today you would lose (18.00) from holding Tscan Therapeutics or give up 3.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NioCorp Developments Ltd vs. Tscan Therapeutics
Performance |
| Timeline |
| NioCorp Developments |
| Tscan Therapeutics |
NioCorp Developments and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NioCorp Developments and Tscan Therapeutics
The main advantage of trading using opposite NioCorp Developments and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NioCorp Developments position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| NioCorp Developments vs. Teck Resources Ltd | NioCorp Developments vs. Sigma Lithium Resources | NioCorp Developments vs. Vale SA ADR | NioCorp Developments vs. Sayona Mining Limited |
| Tscan Therapeutics vs. Tff Pharmaceuticals | Tscan Therapeutics vs. Eliem Therapeutics | Tscan Therapeutics vs. Inhibrx | Tscan Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |